SCHEMBL22939481

SCHEMBL22939481

C=C1/C(=C\CC)CCCN1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904961 0.74 LMNA (0.33) —
SCHEMBL23265523 0.74 LMNA (0.33) —
SCHEMBL6923986 0.66 — —
SCHEMBL14342236 0.66 — —
SCHEMBL19266734 0.65 — —
SCHEMBL26948258 0.64 — —
SCHEMBL13848502 0.62 PIK3CD (0.32) —
SCHEMBL24850781 0.61 — —
SCHEMBL12197802 0.61 — —
SCHEMBL22135496 0.61 OR51E2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021018194-A1 HETEROCYCLIC COMPOUNDS AS BCR-ABL INHIBITORS ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2021-02-04 — — WO disclosed
Send feedback